{
  "primary": "WWTR1",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 (a DUB) physically binds to and deubiquitinates TAZ (WWTR1), leading to its stabilization and promotion of HCC progression (Co-IP evidence).",
  "functions": [
    {
      "function": "TAZ Protein Stability & Hippo Signaling",
      "arrow": "activates",
      "cellular_process": "ATXN3, a deubiquitinase, directly binds to the C-terminal domain of TAZ (WWTR1) via its Josephin domain. This interaction leads to the removal of K48-linked ubiquitin chains from TAZ, thereby preventing its proteasomal degradation.",
      "effect_description": "The stabilization of TAZ protein by ATXN3 leads to its accumulation and enhanced nuclear translocation, promoting the transcriptional activity of TEAD-family transcription factors. This results in the upregulation of target genes that drive cell proliferation, migration, and invasion, contributing to the progression of hepatocellular carcinoma (HCC).",
      "biological_consequence": [
        "ATXN3 binds to TAZ (WWTR1) → ATXN3's Josephin domain deubiquitinates K48-linked ubiquitin chains on TAZ → TAZ is stabilized and protected from proteasomal degradation → Increased nuclear accumulation of TAZ → Activation of TEAD-dependent transcription → Upregulation of pro-proliferative and pro-invasive genes (e.g., CTGF, CYR61) → Progression of Hepatocellular Carcinoma"
      ],
      "specific_effects": [
        "Direct deubiquitination of TAZ (WWTR1)",
        "Inhibition of K48-linked ubiquitination on TAZ",
        "Increased TAZ protein stability and half-life",
        "Upregulation of TAZ target genes, such as CTGF and CYR61"
      ],
      "evidence": [
        {
          "paper_title": "The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ",
          "journal": "Cancer Gene Therapy",
          "year": 2025,
          "relevant_quote": "ATXN3 could interact with, stabilize, and deubiquitylate TAZ in a deubiquitylase-dependent manner. Specifically, this interaction was primarily mediated by the C-terminal domain of TAZ and Josephin domain of ATXN3, thereby inhibiting the K48-linked ubiquitin chain on TAZ. Furthermore, we demonstrated that ATXN3 promoted the occurrence and development of HCC by regulating TAZ.",
          "pmid": "39672915"
        }
      ],
      "pmids": [
        "39672915"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "main_to_primary",
      "function_effect": "activation"
    }
  ],
  "arrow": "activates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "ATXN3, a deubiquitinase, directly binds to the C-terminal domain of TAZ (WWTR1) via its Josephin domain. This interaction leads to the removal of K48-linked ubiquitin chains from TAZ, thereby preventing its proteasomal degradation.",
  "effect": "The stabilization of TAZ protein by ATXN3 leads to its accumulation and enhanced nuclear translocation, promoting the transcriptional activity of TEAD-family transcription factors. This results in the upregulation of target genes that drive cell proliferation, migration, and invasion, contributing to the progression of hepatocellular carcinoma (HCC).",
  "summary": "ATXN3 activates WWTR1 to modulate taz protein stability & hippo signaling, ultimately affecting progression of hepatocellular carcinoma.",
  "evidence": [
    {
      "paper_title": "The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ",
      "journal": "Cancer Gene Therapy",
      "year": 2025,
      "relevant_quote": "ATXN3 could interact with, stabilize, and deubiquitylate TAZ in a deubiquitylase-dependent manner. Specifically, this interaction was primarily mediated by the C-terminal domain of TAZ and Josephin domain of ATXN3, thereby inhibiting the K48-linked ubiquitin chain on TAZ. Furthermore, we demonstrated that ATXN3 promoted the occurrence and development of HCC by regulating TAZ."
    }
  ],
  "initial_pathway": {
    "pathway_name": "Hippo Signaling Pathway",
    "confidence": 0.95,
    "reasoning": "ATXN3 directly deubiquitinates and stabilizes WWTR1 (also known as TAZ), a central transcriptional co-activator in the Hippo signaling pathway."
  },
  "interaction_effect": "activation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --activates--> WWTR1:",
  "protein_a": "ATXN3",
  "protein_b": "WWTR1",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-19T07:06:31.363867Z",
  "last_updated": "2025-12-19T07:06:31.363867Z"
}